About Me
Sepehr Rahmani
Experience & Accomplishments
My scientific background combines biochemistry, molecular pathology, bioinformatics, and software engineering. Throughout my academic training and professional career, I have developed a strong interest in translating computational approaches into practical solutions for molecular diagnostics and precision medicine.
Currently, I work at the University Hospital Zurich, where I develop bioinformatics pipelines, software applications, and databases that support molecular diagnostics and clinical research. Alongside my technical work, I contribute to the coordination of clinical workflows for next-generation sequencing (NGS) diagnostics, combining computational expertise with clinical operations.
Outside of work, I enjoy playing football and have been involved in the sport in various roles, including as a referee. I value teamwork, continuous learning, and tackling complex challenges through collaboration. Get in contact with me to receive more information!
Work & Publications
2026
- Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer — Co-First author
Lung Cancer 218, 109514 (2026).
DOI: https://doi.org/10.1016/j.lungcan.2026.109514 - Co-alterations associated with resistance to EGFR inhibitors in advanced EGFR-positive NSCLC: insights from the precision oncology program in two large international real-world cohorts
npj Precision Oncology (2026).
DOI: https://doi.org/10.1038/s41698-026-01617-5
2025
- Comprehensive genomic profiling for homologous recombination deficiency guides PARP inhibitor therapy recommendations in ovarian cancer — Co-author
Pathology & Oncology Research 31 (2025).
DOI: https://doi.org/10.3389/pore.2025.1612266 - Nodal gamma-delta T-cell lymphoma: expression of TFH-markers causing diagnostic difficulties in a newly described entity — 3rd author
Virchows Archiv (2025).
DOI: https://doi.org/10.1007/s00428-025-04268-2 - Precision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocol
BMJ Open 15(3), e096591 (2025).
DOI: https://doi.org/10.1136/bmjopen-2024-096591
Recommendations
ABOUT Me
I graduated in biochemistry with a focus in bioinformatics and I have the ambition to learn new things everyday and gain more experience! Please contact me if you are interested in further information about my research and experiences.